Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival-Reference-Cited by-同舟云学术

Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival

Published:2019-02-28 Issue:7 Volume:43 Page:1777-1787
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Wu Lu,Tsilimigras Diamantis I.,Paredes Anghela Z.,Mehta Rittal,Hyer J. Madison,Merath Katiuscha,Sahara Kota,Bagante Fabio,Beal Eliza W.,Shen Feng,Pawlik Timothy M.

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/article/10.1007/s00268-019-04966-4/fulltext.html

Reference25 articles.

1. Chang KY, Chang JY, Yen Y (2009) Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Canc Netw 7(4):423–427 (PubMed PMID: 19406042)

2. Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM (2014) Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. J Surg Oncol 110(2):163–170. https://doi.org/10.1002/jso.23605 (PubMed PMID: 24676600)

3. Saha SK, Zhu AX, Fuchs CS, Brooks GA (2016) Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 21(5):594–599. https://doi.org/10.1634/theoncologist.2015-0446 (PubMed PMID: 27000463; PubMed Central PMCID: PMCPMC4861366)

4. Dhanasekaran R, Hemming AW, Zendejas I, George T, Nelson DR, Soldevila-Pico C et al (2013) Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep 29(4):1259–1267. https://doi.org/10.3892/or.2013.2290 (PubMed PMID: 23426976; PubMed Central PMCID: PMCPMC3621732)

5. Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, Messersmith W et al (2017) Impact of facility type and surgical volume on 10-year survival in patients undergoing hepatic resection for hepatocellular carcinoma. J Am Coll Surg 224(3):362–372. https://doi.org/10.1016/j.jamcollsurg.2016.11.011 (PubMed PMID: 27923615)

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and Sex Differences in Genomic Profiling of Intrahepatic Cholangiocarcinoma;Annals of Surgical Oncology;2024-09-09

2. Preoperative platelet count as an independent predictor of long‐term outcomes among patients undergoing resection for intrahepatic cholangiocarcinoma;Journal of Surgical Oncology;2024-08-13

3. Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma;Journal of Cancer Metastasis and Treatment;2024-07-10

4. FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma;The Oncologist;2024-07-10

5. Tumour burden score combined with albumin‐to‐alkaline phosphatase ratio predicts prognosis in patients with intrahepatic cholangiocarcinoma;Journal of Cellular and Molecular Medicine;2024-07